Neurology News

The Alzheimer’s Drug Discovery Foundation has invested $5 million in Coya Therapeutics to help accelerate development and advance drugs to prevent, treat and cure Alzheimer’s disease and related dementias.

DENVER — For the glymphatic system of the brain to function properly, individuals must pay attention to their sleep duration, regulation and deprivation, according to a presenter at the American Academy of Neurology annual meeting.

Insufficient sleep was tied to poorer cognition and attention in adolescents who were classified as having overweight or obesity based on their BMI compared with those with normal weight, according to a recent study in JAMA Neurology.

Women diagnosed with preeclampsia were 2.6 times more likely to develop early-onset dementia during 9 years of follow-up compared with women who did not have a hypertensive disorder of pregnancy, according to registry data.

The FDA has granted 510(k) clearance to a South Korea-based specialized medical AI startup for its non-contrast CT imaging analysis solution to detect intracerebral hemorrhage.

DENVER – Most with menstrual migraine utilize only acute treatments, rather than preventive measures, to address their symptoms, according to research presented at the American Academy of Neurology annual meeting.

Regular use of fish oil supplements was tied to an increased risk of stroke and atrial fibrillation in adults with no prior CVD, according to results of a large prospective cohort study published in BMJ Medicine.

DENVER — Treatment with cannabidiol led to significant seizure reduction in those with focal-onset epilepsy and demonstrated a favorable safety profile, according to research presented at the American Academy of Neurology annual meeting.

The FDA has granted fast track designation to a radioactive fluorinated positron emission tomography tracer for imaging tau protein in those with suspected progressive supranuclear palsy, according to the manufacturer.

An mRNA cancer vaccine developed at University of Florida may have the ability to reprogram the immune system against glioblastoma, findings of a first-in-human trial showed.